Silent myocardial ischemia: clinical characteristics, underlying mechanisms, and implications for treatment

The American Journal of Medicine
R W Nesto, R T Phillips

Abstract

A great deal of interest is being generated by the possibility that patients with coronary artery disease and typical angina pectoris may also experience periods of ischemia during activities of daily living that are not necessarily associated with angina or increased myocardial oxygen demand. It might be that the majority of ischemic episodes during daily life are not preceded by increases in myocardial oxygen demand, and are probably related to dynamic changes in coronary blood flow. Questions still remain, however, regarding the prevalence of asymptomatic ischemia in patients who present with effort angina and positive results on exercise tolerance tests. Therefore, in susceptible patients with coronary artery disease, calcium channel blockers, especially nifedipine, may be of particular benefit since they decrease myocardial oxygen demand during effort and may increase coronary blood flow, thereby aborting asymptomatic ischemia, which tends to occur at low levels of cardiac oxygen demand. It appears that a greater awareness of the total ischemic burden, i.e., the sum total of symptomatic and asymptomatic and exertional and nonexertional ischemia, may facilitate individualization of therapy for patients with coronary artery ...Continue Reading

References

Mar 1, 1977·The American Journal of Cardiology·S J Schang, C J Pepine
Nov 21, 1985·The New England Journal of Medicine·J E MullerT Robertson
May 8, 1986·The New England Journal of Medicine·S O GottliebG Gerstenblith
May 1, 1986·The American Journal of Cardiology·J E DeanfieldA P Selwyn
Aug 1, 1985·Journal of the American College of Cardiology·D R BresnahanH C Smith
Feb 1, 1969·The American Journal of Cardiology·A M Master, A J Geller
Oct 1, 1981·The American Journal of Cardiology·S E Epstein, T L Talbot
Dec 1, 1984·The American Journal of Cardiology·J E DeanfieldA P Selwyn
Mar 1, 1983·Journal of the American College of Cardiology·P F Cohn
Nov 1, 1983·British Heart Journal·A A QuyyumiK Fox
Mar 1, 1983·Journal of the American College of Cardiology·S ChierchiaA Maseri
Mar 1, 1983·Journal of the American College of Cardiology·A C CecchiP F Fazzini
Mar 1, 1983·Journal of the American College of Cardiology·G S Uhl, V Froelicher
Mar 1, 1980·The American Journal of Cardiology·P F Cohn
Oct 1, 1980·British Heart Journal·V BalasubramanianE B Raftery
Oct 20, 1961·Science·N J HOLTER

❮ Previous
Next ❯

Citations

Jul 1, 1988·Journal of the American College of Cardiology·S W ZarichR W Nesto
Feb 21, 1987·Lancet
Sep 13, 2002·Journal of the American College of Cardiology·Tauqir Y GorayaVéronique L Roger
Jan 10, 2001·Endocrinology and Metabolism Clinics of North America·B W Paty
Jan 1, 1988·American Heart Journal·P F Cohn
Aug 1, 1989·The American Journal of Cardiology·E Ben-AriJ J Kellermann
Nov 1, 1988·Pacing and Clinical Electrophysiology : PACE·D KocovicP Stojanov
Jan 1, 1990·International Journal of Cardiology·R J Northcote, T J Higgins
Dec 13, 2005·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Christopher Heeschen
Jan 1, 1988·Experimental Lung Research·W R AbramsG Weinbaum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.